# Preventive Effects of Avocado/Soybean Unsaponifiables on Complex Regional Pain Syndrome Type I in a Rat Model

## TL;DR

This study shows that avocado/soybean unsaponifiables (ASU) can prevent CRPS-I-like symptoms in rats by reducing inflammation and oxidative stress.

## Contribution

This is the first study to demonstrate ASU's preventive effects on CRPS-I in a rat model.

## Key findings

- ASU significantly reduced mechanical allodynia, paw edema, and temperature asymmetry in rats.
- ASU suppressed pro-inflammatory cytokines and oxidative stress markers in hind paw tissue.
- Early ASU treatment showed multimodal protective effects against CRPS-I features.

## Abstract

Background and Object: Complex Regional Pain Syndrome Type I (CRPS-I) is a debilitating condition often triggered by trauma, with early pathophysiology driven by neuroinflammation and oxidative stress. Avocado/soybean unsaponifiables (ASU) possess potent anti-inflammatory and antioxidant properties but have never been tested for CRPS-I prevention. This study investigated the preventive effects of early systemic administration of ASU on the development of CRPS-I-like features in a validated rat model of tibial fracture and cast immobilization. Methods: Twenty adult male Wistar rats were randomized into two groups (n = 10/group): a CRPS-I (Vehicle) group receiving daily intraperitoneal saline, and a CRPS-I+ASU group receiving daily ASU (300 mg/kg/day). The model was induced via a right tibial fracture followed by 28 days of cast immobilization. Treatment began immediately post-fracture. Behavioral outcomes (mechanical allodynia via von Frey, paw edema, temperature asymmetry) were assessed pre-fracture and on day 29. Subsequently, levels of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and oxidative stress markers (TAS, TOS, OSI) were measured in the ipsilateral hind paw tissue. Results: ASU treatment significantly attenuated the development of CRPS-I-like manifestations. Compared to the vehicle group, the ASU group exhibited a markedly lower median percentage decrease in mechanical withdrawal threshold (30.20% [22.56–37.01] vs. 51.45% [47.84–61.11], p = 0.001), reduced temperature asymmetry (0.75 °C [0.55–1.00] vs. 1.95 °C [1.80–2.33], p < 0.001), and less paw edema (8.35% [7.06–11.29] vs. 14.75% [12.66–19.20], p = 0.004). Biochemically, ASU treatment significantly suppressed tissue levels of IL-1β, IL-6, and TNF-α (all p < 0.001), enhanced total antioxidant status (TAS), and reduced total oxidant status (TOS) and the oxidative stress index (OSI) (all p < 0.001). Conclusions: Early systemic administration of ASU significantly prevents the development of nociceptive, vascular, inflammatory, and oxidative disturbances in a rat model of CRPS-I. These findings highlight ASU’s multimodal protective effects at the tissue level and position it as a promising candidate for early preventive intervention in post-traumatic CRPS-I.